A Rare Complication of Thymoma: Pure White Cell Aplasia in Good's Syndrome.
Kim UyElizabeth LevinPawel MrozFaqian LiSurbhi ShahPublished in: Case reports in hematology (2019)
Pure white cell aplasia (PWCA) is a rare manifestation of thymoma. It is characterized by agranulocytosis with absent myeloid precursors in the bone marrow and normal hematopoiesis for other cell lines. Here we describe a 65-year-old female patient who presented with three days of fever and night sweat. Chest CT revealed an anterior mediastinal mass. A biopsy of the mass confirmed a diagnosis of thymoma mixed type A and B2. The patient developed a severe neutropenia, and her bone marrow revealed significantly decreased neutrophil-lineage cells, rare to absent B cells, and defective T cells, consistent with PWCA. Following thymectomy, a complete resolution of PWCA was achieved via multimodality therapy of intravenous immunoglobulins, granulocyte colony-stimulating factor, and immunosuppressant. This report highlights the care complexity regarding treatment choices and decision to perform thymectomy in patients presenting with PWCA.
Keyphrases
- bone marrow
- single cell
- myasthenia gravis
- case report
- mesenchymal stem cells
- cell therapy
- healthcare
- induced apoptosis
- palliative care
- ultrasound guided
- computed tomography
- stem cells
- magnetic resonance imaging
- dendritic cells
- high dose
- early onset
- pain management
- peripheral blood
- cell cycle arrest
- fine needle aspiration
- oxidative stress
- low dose
- decision making
- chronic pain
- single molecule
- immune response
- cell death